Device / Technology News

RSS

A crystal ball into your future health!

Imagine knowing just what diseases you are likely to suffer from in your lifetime thanks to the sequencing of your genes. That is exactly what Professor Stephen Quake knows, because he has had his entire genome sequenced and studied. In fact he was in the news last year as well when he used new technology to sequence his genetic code for less than $50,000.

29 Apr 2010

ZOLL Medical's second-quarter revenues up 15% to $107.1 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and software solutions, today announced that revenues for the second quarter of fiscal 2010 increased 15% to $107.1 million, compared to revenues in the second quarter of last year of $92.7 million. Revenue results included a positive foreign exchange impact of approximately $2.2 million, compared to the second quarter of fiscal 2009.

29 Apr 2010

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.

29 Apr 2010

NeoGenomics first-quarter revenue up 22%

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2010.

29 Apr 2010

Orion Health Rhapsody Integration Engine to be deployed across Philips' healthcare informatics solutions

Royal Philips Electronics today announced an agreement with Orion Health™, a leading provider of integration solutions in healthcare, to deploy the Orion Health Rhapsody® Integration Engine across Philips' portfolio of healthcare informatics solutions.

From Philips Healthcare 29 Apr 2010

China Medical Technologies' AUTOMAGLIA 90 analyzer and Down Syndrome Screening receive SFDA approval

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer as well as Down Syndrome screening kit from the State Food and Drug Administration of China.

29 Apr 2010

Artificial heart to be a reality soon, expect researchers

There is good news for heart patients waiting in line for a heart transplant. A team of researchers in Queensland, Malaysia, Germany and Japan are working on an artificial heart. They plan to try it first in sheep.

29 Apr 2010

New FineThanx phone system gives peace of mind to elderly patients

In a new system, telephone calls twice a day find out how an aging loved one is doing. Then the system reports back the good news or bad.

29 Apr 2010

Tomophase receives seventh U.S. Patent for OCTIS component

Tomophase Corporation, a leading developer of non-invasive optical coherence tomography (OCT) tissue imaging devices, announced today that it has received notification of the issuance of its seventh patent: Delivering Light via Optical Waveguide and Multi-view Optical Probe Head, U. S. Patent # 7,706,646.

29 Apr 2010

Health care providers now have access to free toolkit to improve youth smoking cessation programs

Health care providers and educators nationwide who run youth smoking cessation programs now have access to a free toolkit to improve their programs.

29 Apr 2010

New MDC tool provides alternative choices to user's current prescription drugs

Healthcare reform legislation has enacted changes that will significantly affect the Medicare Part D prescription drug program. The most immediate impact of the reform aims to close the "donut hole", a component of the benefit design in which seniors must pay the full cost for their drugs themselves.

29 Apr 2010

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that results from a pre-clinical study showed significant improvement in the delivery and half life of Å6, a proprietary peptide treatment for ovarian cancer currently in Phase 2 development by Angstrom Pharmaceuticals. Specifically, the incorporation of NexACT® enabled the dose of Å6 to be cut by half, or from twice per day to once per day delivered subcutaneously, while achieving the same level of efficacy in the mouse lung metastasis model.

29 Apr 2010

Cardiac Science responds to FDA communications on AED recall

Cardiac Science Corporation, responded to FDA communications released yesterday related to the AED recall first announced in November, 2009. The Agency communication specifies additional affected models and offers further guidance to users of AEDs affected by potential component defects in some of the Company's AEDs.

29 Apr 2010

miacom diagnostics announces new tests for faster diagnosis of sepsis

"Conventional PCR tests (PCR is short for polymerase chain reaction, a highly sensitive method of detecting nucleic acids) require several hours to produce a result. lucesco Bacteremia IVD panels are not only much faster with a result after only 30 minutes, they are also much more cost-efficient.

29 Apr 2010

Emdat launches DaRT solution to help physicians utilize EMRs more efficiently

Emdat announces the launch of DaRT, or Discrete accurate Reportable Transcription, a solution that enables more efficient utilization of electronic medical records by seamlessly integrating with Emdat's online medical transcription platform.

29 Apr 2010

$Ageing population prone to bone fractures drives South African joint replacement market$

Ageing population prone to bone fractures drives South African joint replacement market

The joint replacement market in South Africa is set to experience continued growth in the medium to long term, driven by an ageing population that is prone to cartilage degeneration and bone fractures. The introduction of innovative products with enhanced durability and longevity as well as safer operation techniques is further boosting growth in this market.

29 Apr 2010

Astrazeneca settles drug marketing lawsuit, plea deal rejected for possibly defective heart device maker

The New York Times: AstraZeneca has settled a case and agreed to pay $520 million after federal investigations into its marketing practices for a schizophrenia drug, Seroquel. The announcement came Tuesday from Attorney General Eric Holder. Government officials, including Health and Human Services Secretary Kathleen Sebelius, said the company paid illegal kickbacks to doctors to promote drugs for unapproved uses by children, the elderly, veterans and prisoners, which is illegal under federal law.

29 Apr 2010

Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection

The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects.

29 Apr 2010

Remote heart rhythm treatment procedure using a robotic arm

A pioneering world first robotics system operation is to be conducted at Glenfield Hospital Leicester thanks to expertise at the University of Leicester and University Hospitals of Leicester.

29 Apr 2010

Realton closes Series B financing

Realton Corporation, a pioneer in developing diode-pumped laser systems initially targeted to treat enlarged prostate, today announced the closing of its Series B financing co-led by OrbiMed Advisors and China Healthcare Partnership. Existing investor CSV Capital Partners will also participate in the financing. The financing will be used primarily to enhance Realton's marketing and distribution networks, expand its manufacturing capabilities and pursue new technology development.

29 Apr 2010

Device / Technology News

A crystal ball into your future health!

ZOLL Medical's second-quarter revenues up 15% to $107.1 million

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

NeoGenomics first-quarter revenue up 22%

Orion Health Rhapsody Integration Engine to be deployed across Philips' healthcare informatics solutions

China Medical Technologies' AUTOMAGLIA 90 analyzer and Down Syndrome Screening receive SFDA approval

Artificial heart to be a reality soon, expect researchers

New FineThanx phone system gives peace of mind to elderly patients

Tomophase receives seventh U.S. Patent for OCTIS component

Health care providers now have access to free toolkit to improve youth smoking cessation programs

New MDC tool provides alternative choices to user's current prescription drugs

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

Cardiac Science responds to FDA communications on AED recall

miacom diagnostics announces new tests for faster diagnosis of sepsis

Emdat launches DaRT solution to help physicians utilize EMRs more efficiently

Ageing population prone to bone fractures drives South African joint replacement market

Astrazeneca settles drug marketing lawsuit, plea deal rejected for possibly defective heart device maker

Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection

Remote heart rhythm treatment procedure using a robotic arm

Realton closes Series B financing

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News